INTERNATIONAL PATENT: ASTRAZENECA IRELAND LIMITED FILES APPLICATION FOR "SGLT2 INHIBITORS AND BAXDROSTAT FOR TREATING CHRONIC KIDNEY DISEASE AND HYPERTENSION"

GENEVA, June 23 -- ASTRAZENECA IRELAND LIMITED (College Business & Technology Park,Blanchardstown Road North, Dublin 15Dublin, D15 R925) filed a patent application (PCT/EP2024/086083) for "SGLT2 INHIBITORS AND BAXDROSTAT FOR TREATING CHRONIC KIDNEY DISEASE AND HYPERTENSION" on Dec 12, 2024. With publication no. WO/2025/125513, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LITTLE, Dustin (ASTRAZENECA PHARMACEUTICALS LP,1800 Concord Pike, P.O. Box 15437Wilmington, Delaware 19850-5437), ROSSERT, Jerome (ASTRAZENECA PHARMAC...